Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pain × Palonosetron × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 27 Nausea 20 Neoplasms 8 Breast Neoplasms 6 Lymphoma 3 Stomach Neoplasms 2 Rectal Neoplasms 2 Lymphoma, Non-Hodgkin 2 Leukemia 2 Hematologic Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms, Male 2 Weight Loss 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Sarcoma 1 Pancreatic Neoplasms 1 Pain 1 Neoplasms, Germ Cell and Embryonal 1 Multiple Myeloma 1 Melanoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1 Hematologic Diseases 1 Glioma 1 Genital Neoplasms, Female 1 Gastrointestinal Neoplasms 1

Interventions

Surveys and Questionnaires 15 Acupuncture Therapy 15 Fentanyl 14 Morphine 13 Acetaminophen 13 Analgesia 12 Lidocaine 11 Ketamine 11 Bupivacaine 11 Methadone 10 Therapeutics 9 Ropivacaine 9 Psychiatric Rehabilitation 9 Oxycodone 9 Hydromorphone 7 Saline Solution 6 Radiotherapy 6 Early Intervention, Educational 6 Zoledronic Acid 5 Yoga 5 Water 5 Music Therapy 5 Methods 5 Control Groups 5 Transcutaneous Electric Nerve Stimulation 4 Therapeutic Touch 4 Physical Therapy Modalities 4 Massage 4 Ketorolac 4 Exercise 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05315999 2025-03-19

ProTreat

University Hospital Freiburg

Phase 2 Completed

Nausea, Pain, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡